Sym-021

N/A

Report date: 2024/03/04 10:41:06

Base Information

Drug NameSym-021
Drug Alias NameAnti-PD-1 (Symphogen)Sym-021Sym021S-95016
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionProgrammed cell death protein 1 blockers
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesFrance +[4] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSymphogen A/S
China Registration ClassN/A

Develop Information

Active CompaniesSymphogen A/S
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasm MetastasisLymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A